A Clinical Study to Evaluate the Effect of Durva Granules in Women with Abnormal Uterine Bleeding

Evaluation of the Efficacy of Durva Granules (Cynodon dactylon) in Raktapradar (Abnormal Uterine Bleeding)-A Single Arm Clinical Study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103637

Enrollment

Registered

2026-02-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient between age group of 12 to 45 years of age, having symptoms of Raktapradar as excessive and /or prolonged menstrual bleeding ; intermenstrual bleeding.

Exclusion criteria

Exclusion criteria: Patients with blood coagulopathies Malignant Pathology, Traumas Patients with severe anemia Patients with IUCD Patients taking OC Pills or on hormonal therapy.

Design outcomes

Primary

Measure	Time frame
Reduction in quantity of bleeding ,duration of bleeding, pain and other symptoms after the use of Durva granules in women with Raktapradar (Abnormal Uterine Bleeding) Timepoint: Study will be of 7 days follow ups on 4th and 7th day.	—

Secondary

Measure	Time frame
Reduction PBLAC and NRS Scale.Timepoint: Study will be of 7 days follow ups on 4th and 7th day.	—

Countries

India

Contacts

Public ContactDr Pratiksha Babasaheb Andhale

Dr. DY Patil College Of Ayurved And Research Center ,Pimpri, Pune

pradnyashirke2@gmail.com9623446110

Outcome results